Last update 05 Dec 2025

Interleukin-7 and Chemokine (C-C Motif) Ligand 19-expressing CD19-CAR-T cells(First Affiliated Hospital of Zhejiang University)

Overview

Basic Info

Drug Type
CAR-T
Synonyms-
Target
CD19 x IL-7
Action
modulators
Mechanism
CD19 modulators(B-lymphocyte antigen CD19 modulators), IL-7 modulators(interleukin 7 modulators)
Therapeutic Areas
NeoplasmsImmune System DiseasesHemic and Lymphatic Diseases+ [1]
Active Indication-
Inactive Indication
Aggressive B-Cell Non-Hodgkin LymphomaDiffuse large B-cell lymphoma refractoryIndolent B-Cell Non-Hodgkin Lymphoma+ [1]
Originator Organization
The First Affiliated Hospital, Zhejiang University Sch of MedThe First Affiliated Hospital, Zhejiang University Sch of Med
Active Organization-
Inactive Organization
The First Affiliated Hospital, Zhejiang University Sch of MedThe First Affiliated Hospital, Zhejiang University Sch of Med
License Organization-
Drug Highest PhasePendingPhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Interleukin-7 and Chemokine (C-C Motif) Ligand 19-expressing CD19-CAR-T cells(First Affiliated Hospital of Zhejiang University)
NCT03929107
/ Unknown statusPhase 2IIT
Interleukin-7 and Chemokine (C-C Motif) -Ligand 19-expressing CD19-CAR-T for Refractory/Relapsed B Cell Lymphoma
100 Clinical Results associated with Interleukin-7 and Chemokine (C-C Motif) Ligand 19-expressing CD19-CAR-T cells(First Affiliated Hospital of Zhejiang University)
Login to view more data
100 Translational Medicine associated with Interleukin-7 and Chemokine (C-C Motif) Ligand 19-expressing CD19-CAR-T cells(First Affiliated Hospital of Zhejiang University)
Login to view more data
100 Patents (Medical) associated with Interleukin-7 and Chemokine (C-C Motif) Ligand 19-expressing CD19-CAR-T cells(First Affiliated Hospital of Zhejiang University)
Login to view more data
100 Deals associated with Interleukin-7 and Chemokine (C-C Motif) Ligand 19-expressing CD19-CAR-T cells(First Affiliated Hospital of Zhejiang University)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Aggressive B-Cell Non-Hodgkin LymphomaPhase 2
China
The First Affiliated Hospital, Zhejiang University Sch of MedThe First Affiliated Hospital, Zhejiang University Sch of Med
28 Mar 2019
Diffuse large B-cell lymphoma refractoryPhase 2
China
The First Affiliated Hospital, Zhejiang University Sch of MedThe First Affiliated Hospital, Zhejiang University Sch of Med
28 Mar 2019
Indolent B-Cell Non-Hodgkin LymphomaPhase 2
China
The First Affiliated Hospital, Zhejiang University Sch of MedThe First Affiliated Hospital, Zhejiang University Sch of Med
28 Mar 2019
Mediastinal large B-cell lymphomaPhase 2
China
The First Affiliated Hospital, Zhejiang University Sch of MedThe First Affiliated Hospital, Zhejiang University Sch of Med
28 Mar 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free